latest news releases from the newsroom
Nomination Committee's proposal for the OMX Board of Directors
STOCKHOLM, Sweden, Dec. 22, 2004 (PRIMEZONE) -- OMX's Nomination Committee, comprising Marcus Wallenberg (Committee Chairman), Eva Halvarsson, KG Lindvall, Tom Ruud and Olof Stenhammar (convening member), have decided to propose to the Extraordinary Board Meeting OMX intends to hold on February 3, 2005, that the following new Board members be elected to serve until the 2005 Annual General Meeting is held:
Volvo Aero completes acquisition of Aero-Craft
GOTEBORG, Sweden, Dec. 22, 2004 (PRIMEZONE) -- Volvo Aero's planned acquisition of the Aero-Craft company has now been completed. As a result, the strategic alliance with Carlton Forge Works can be realized. Consequently, Volvo Aero can now expand its offering of specialized components to include fan cases.
Skanska signs contract for sale of Myresjohus
STOCKHOLM, Sweden, Dec. 22, 2004 (PRIMEZONE) -- Skanska and Industri Kapital have signed a binding agreement covering the sale of Myresjohus. The sale is conditional upon the approval of the appropriate authorities.
Tele2 Acquires Votec Mobile in Russia
NEW YORK and STOCKHOLM, Sweden, Dec. 22, 2004 (PRIMEZONE) -- Tele2 AB, ("Tele2"), (Nasdaq:TLTOA) (Nasdaq:TLTOB) (Stockholmsborsen:EL2A)(Stockholmsborsen:TEL2B), the leading alternative pan-European telecommunications company, today announced that it has acquired Votec Mobile, a mobile operator with a GSM licence in the territory of Voronezh, in Southern Russia.
AB Volvo Announces Repurchase of 380,000 B Shares and 15,000 A Shares
GOTEBORG, Sweden, Dec. 22, 2004 (PRIMEZONE) -- Further to the decision taken by AB Volvo's Board of Directors on June 17, 2004, regarding repurchase of own shares, AB Volvo has, on Tuesday, December 21, acquired 380,000 series B shares. The shares were traded between SEK 260.50 and 262.50 with an average price of SEK 261.64. And has acquired 15,000 series A shares. The shares were traded between SEK 250.50 and 252.00 with an average price of SEK 251.41.
Actelion Initiates Phase IIb/III Program With Clazosentan
ALLSCHWIL, Switzerland, Dec. 22, 2004 (PRIMEZONE) -- Actelion Ltd (Other OTC:ALIOF) (SWX:ATLN) announced today it has initiated the comprehensive global Phase IIb/III development program for clazosentan, an intravenous endothelin receptor antagonist. This follows the completion of discussions with regulatory authorities in both the US and the European Union on all aspects of the clinical program, including clinical efficacy endpoints.
CALAMOS Strategic Total Return Fund (CSQ) Announces Regular Dividend
NAPERVILLE, Ill., Dec. 21, 2004 (PRIMEZONE) -- CALAMOS Strategic Total Return Fund (NYSE:CSQ) (Cusip No.: 128125 10 1) announced today the declaration of a regular dividend distribution of $0.075 per share, payable on January 21, 2005, to shareholders of record on December 30, 2004. Assuming the foregoing, the ex-dividend date should be December 28, 2004.